Deals this week: Milestone Pharmaceuticals, Homology Medicines, Ultragenyx Pharmaceutical

Canadian cardiovascular drug development company Milestone Pharmaceuticals has secured $55m through a series C funding round led by Novo Holdings.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news